Replies to post #76921 on Biotech Values

[pharmaclown35]

i don't. sat in the CLARITY presentation today. I saw four cases of cancer. where was the 5th? i think the FDA will not lower their standard safety bar, esp if it is going to set the bar for approval criteria for these new orals.

NVS has tons of pt data.

http://www.ft.com/cms/s/2/363484d8-332a-11de-9316-00144feabdc0,dwp_uuid=e8477cc4-c820-11db-b0dc-000b5df10621.html

this article seems to be the only negative one on cladribine right now.